$523.88
Value $3.89T
MSFT and NUTX stock compared: price, dividend, valuation and results, from SEC filings.
$523.88
Value $3.89T
$173.67
Value $1.2B
Microsoft (MSFT) has a market value of $3.89T and Nutex Health (NUTX) $1.2B. The P/E is 27.3 for MSFT and 7.4 for NUTX. Dividend yield: MSFT 0.69%, NUTX none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MSFT$3.89T
NUTX$1.2B
MSFT is 3,214 times NUTX
Revenue, 12 months
MSFT$346B
NUTX$797M
MSFT is 435 times NUTX
Net income, 12 months
MSFT$143B
NUTX$165M
MSFT is 866 times NUTX
Operating margin
MSFT47.1%
NUTX39.0%
8.1 points apart
ROIC
MSFT28.7%
NUTX61.1%
32.4 points apart
P/E
MSFT27.3
NUTX7.4
MSFT is 3.7 times NUTX
Dividend yield
MSFT0.7%
NUTX0.0%
0.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
Prices are not available right now.
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MSFTMicrosoftNUTXNutex Health
| Price | $523.88 | $173.67 |
|---|---|---|
| Market value | $3.89T | $1.2B |
| Enterprise value (EV) | $3.93T | $1.3B |
| P/E | 27.3 | 7.4 |
| P/E, 5-year median | 35.2 | – |
| P/B | 8.3 | 2.8 |
| EV/EBIT | 24.1 | 4.2 |
| Free cash flow yield | 1.5% | 20.5% |
| Revenue, 12 months | $346B | $797M |
|---|---|---|
| Net income, 12 months | $143B | $165M |
| Free cash flow, 12 months | $60.0B | $248M |
| Earnings per share, 12 months | $19.16 | $23.22 |
| Revenue growth, year on year | 17.8% | 82.4% |
| Revenue growth a year, past | +14.6%over 5 years | +26.1%over 5 years |
| EPS growth a year, past | +17.4%over 5 years | -17.2%over 5 years |
| Gross margin | 67.7% | 47.8% |
|---|---|---|
| Operating margin | 47.1% | 39.0% |
| Net margin | 41.2% | 20.7% |
| ROIC | 28.7% | 61.1% |
| ROE | 34.3% | 45.2% |
| Cash | $64.5B | $250M |
|---|---|---|
| Total debt | $134B | $365M |
| Net debt / EBITDA | 0.2 | 0.3 |
| Interest cover | 50.6× | 16.2× |
| Dividend yield | 0.7% | – |
|---|---|---|
| Dividend per share, 12 months | $3.64 | – |
| Dividend growth a year, past | +10.2%over 5 years | – |
| Buyback yield | 0.6% | 0.4% |
| Shareholder yield | 1.3% | 0.4% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Microsoft ($3.89T) is about 3,214.4 times Nutex Health ($1.2B), at today's prices.
The dividend yield at today's price is 0.69% for Microsoft and none for Nutex Health. Over the last twelve months they paid $3.64 and – per share.
At today's price, the P/E is 27.3 for MSFT and 7.4 for NUTX. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 41.2% for Microsoft and 20.7% for Nutex Health, and the operating margin 47.1% and 39.0%. Revenue was $346B and $797M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.